T1	Participants 64 120	markedly obese adolescents with normal glucose tolerance
T2	Participants 393 443	obese children with normal glucose tolerance (NGT)
T3	Participants 517 824	28 obese [mean body mass index (BMI): 40.3 +/- 5.7 kg/m(2)], insulin-resistant [homeostasis model assessment - insulin resistance: 7.6 +/- 2.8 and whole body insulin sensitivity index (WBISI): 1.5 +/- 0.7] adolescents (age 15.0 +/- 1.3 yr) randomized to MET (n = 15, dose 1500 mg daily) or placebo (n = 13).
